Use of PBPK modeling to reduce uncertainty in risk assessment: Example of manganese
111010Hamner.pdf
(1.66 MB)
Document Date:
Document Keywords
physiologically based pharmacokinetic modeling
Physiologically based pharmacokinetics (PBPK)
manganese
Document Category
Presentation
Meeting
Biomonitoring California Scientific Guidance Panel Meeting, November 2010
This page is tagged as Spanish. View English site.
